Chronic pulmonary aspergillosis kills about 80 percent of those suffering from it over five years unless it is treated with long-term antifungals. The European Respiratory Society estimates that 3 million people worldwide have CPA. The infection is particularly difficult to manage and the societies expect these clinical guidelines to be a helpful resource for those treating affected patients.
“This is the first guideline on chronic pulmonary aspergillosis worldwide,” Andrew Ullman, a professor at the Julius Maximilian University of Würzberg and chairman of the ESCMID’s fungal infection study group, said in a statement. “It is the result of another joint effort of ESCMID and ERS experts who, in a truly interdisciplinary collaboration, prepared and published guidance for colleagues on a group of complex diseases that is difficult to manage. Aspergillosis is more than chronic lung infection and a larger document addressing all aspects of aspergillosis infections is under preparation by EFISG.”
More articles on infection control:
CDC: Source of UPMC mold that killed 3 could not be found
FDA relaxes ban on blood donations from gay, bisexual men
WHO publishes list of emerging diseases like to cause major epidemics
